4.6 Review

Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new strategies

Journal

GENE
Volume 538, Issue 2, Pages 217-227

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.gene.2013.12.019

Keywords

RNA interference; Gene-silencing; RNAi delivery; Therapeutics

Funding

  1. Innovation and Technology Fund of the Hong Kong Special Administrative Region, China [UIM/230]
  2. Basic Research for Shenzhen Municipal Science and Technology Programme [JCYJ20120619153045369]

Ask authors/readers for more resources

During recent decades there have been remarkable advances in biology, in which one of the most important discoveries is RNA interference (RNAi). RNAi is a specific post-transcriptional regulatory pathway that can result in silencing gene functions. Efforts have been done to translate this new discovery into clinical applications for disease treatment. However, technical difficulties restrict the development of RNAi, including stability, off-target effects, immunostimulation and delivery problems. Researchers have attempted to surmount these barriers and improve the bioavailability and safety of RNAi-based therapeutics by optimizing the chemistry and structure of these molecules. This paper aimed to describe the principles of RNA interference, review the therapeutic potential in various diseases and discuss the new strategies for in vivo delivery of RNAi to overcome the challenges. (C) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available